All posts by: Michael Zand

About Michael Zand

Brain Cells From Stem Cells Train Machine To ID Neurotoxins – Forbes

Continue reading

2015-09-21 NEWS

Forbes

Brain Cells From Stem Cells Train Machine To ID Neurotoxins
Forbes
MS: Human pluripotent stem cells were used to derive “precursor” cell types representing distinct components of the developing human brain that have been implicated in developmental neurotoxicity, including (1) neural progenitor cells (which

and more »

Continue reading

2015-09-21 NEWS

Medical Xpress

Scientists sequence genome of worm that can regrow body parts, seeking stem
Medical Xpress
The flatworm is ideal for studying stem cells, says lead author Kaja Wasik, who conducted the work as a PhD student in Hannon’s lab along with co-lead author James Gurtowski from Schatz’s lab. “The worms are just like floating sacks full of stem cells, …
Researchers Sequence Genome, Transcriptome of Regenerative FlatwormGenomeWeb

all 4 news articles »

Continue reading

2015-09-21 NEWS

EurekAlert (press release)

Scientists sequence genome of worm that can regrow body parts, seeking stem
EurekAlert (press release)
“This and other regenerating flatworms have the same kind of pathway operating in stem cells that is responsible for their remarkable regenerative capabilities. As we started to try to understand the biology of these stem cells, it very quickly became
Researchers Sequence Genome, Transcriptome of Regenerative FlatwormGenomeWeb

all 4 news articles »

Continue reading

2015-09-21 NEWS

University of Wisconsin-Madison

Stem cell-derived ‘organoids’ help predict neural toxicity
University of Wisconsin-Madison
21 issue of the Proceedings of the National Academy of Sciences (PNAS), the team describes a new approach for predicting developmental neurotoxicity that uses stem cells to model features of the developing human brain that could be targeted by toxic …
Predicting Neural ToxicityThe UCSB Current

all 4 news articles »

Continue reading

2015-09-21 NEWS

Lymphoma News Today

Clinical Trial of Blood Stem Cell Transplant in Lymphoma Currently Enrolling
Lymphoma News Today
The National Cancer Institute (NCI) at the National Institutes of Health is currently enrolling participants for a stem cell transplant clinical trial. The phase II/III trial is intended to study an autologous (taken from the person’s own body